Evaluation & Treatment of Systemic Sclerosis-ILD in the New Decade
A Combined Immunosuppressive Regimen for ILD MDA5-Positive Dermatomyositis
Nintedanib Slows Lung Deterioration in General Fibrosing Interstitial Lung Disease
Catch Your Breath: Insights into ILD in RA Patients
Myositis Autoantibodies as Biomarkers
MUC5B Promoter Variant Associated with RA with Interstitial Lung Disease
4 Rheumatoid Arthritis Therapy Principles, & New Drug Info
Treatment Tips for Pulmonary Arterial Hypertension & ILD
